Daniel Cimbora

3.7k citations

36 papers · 2.2k indexed · 1 hit paper · h-index 21

Impact in

Virology top 2%
- HIV Research and Treatment
Cell Biology top 5%
- Cellular transport and secretion

Papers in ⓘ

Molecular Biology 18
- Genomics and Chromatin Dynamics 6
- DNA and Nucleic Acid Chemistry 5
- Epigenetics and DNA Methylation 4
Pathology and Forensic Medicine 13
- Multiple Sclerosis Research Studies 11

Co-authors: Mark Groudine (7 shared papers)Andreas Reik (4 shared papers)Dirk Schübeler (3 shared papers)David I. K. Martin (2 shared papers)Claire Francastel (2 shared papers)Elliot Epner (4 shared papers)Agnes Telling (3 shared papers)Thaylon Davis (2 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (4 papers)Molecular and Cellular Biology (4 papers)Multiple Sclerosis Journal (3 papers)Cancer Research (3 papers)Multiple Sclerosis and Related Disorders (2 papers)
Partner nations: United States Germany Japan

In The Last Decade

Daniel Cimbora

35 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

The Protein Network of HIV Budding 2003 · 689 citations

Peers

Countries citing papers authored by Daniel Cimbora

Since Specialization

Citations

This map shows the geographic impact of Daniel Cimbora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Cimbora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Cimbora more than expected).

Fields of papers citing papers by Daniel Cimbora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Cimbora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Cimbora. The network helps show where Daniel Cimbora may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Cimbora, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Cimbora Line = papers co-authored together Daniel Cimbora links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Protein Network of HIV Budding Cell ·Uta K. von Schwedler, Melissa D. Stuchell, Bárbara Müller, Diane M. Ward, Hyo-Young Chung, Eiji Morita, Hubert E. Wang, Thaylon Davis, Gong-Ping He, Daniel Cimbora, Anna I. Scott, Hans‐Georg Kräusslich, Jerry Kaplan, Scott G. Morham, Wesley I. Sundquist Hit paper breakdown →	2003	689
2	Nuclear localization and histone acetylation: a pathway for chromatin opening and transcriptional activation of the human β-globin locus Genes & Development ·Dirk Schübeler, Claire Francastel, Daniel Cimbora, Andreas Reik, David I. K. Martin, Mark Groudine	2000	279
3	The β-Globin LCR Is Not Necessary for an Open Chromatin Structure or Developmentally Regulated Transcription of the Native Mouse β-Globin Locus Molecular Cell ·Elliot Epner, Andreas Reik, Daniel Cimbora, Agnes Telling, M. A. Bender, Steve Fiering, Tariq Enver, David I. K. Martin, Marion Kennedy, Gordon Keller, Mark Groudine	1998	170
4	The Locus Control Region Is Necessary for Gene Expression in the Human β-Globin Locus but Not the Maintenance of an Open Chromatin Structure in Erythroid Cells Molecular and Cellular Biology ·Andreas Reik, Agnes Telling, Galynn Zitnik, Daniel Cimbora, Elliot Epner, Mark Groudine	1998	143
5	Genomic Targeting of Methylated DNA: Influence of Methylation on Transcription, Replication, Chromatin Structure, and Histone Acetylation Molecular and Cellular Biology ·Dirk Schübeler, Matthew C. Lorincz, Daniel Cimbora, Agnes Telling, Yong-Quing Feng, Eric E. Bouhassira, Mark Groudine	2000	134
6	Long-Distance Control of Origin Choice and Replication Timing in the Human β-Globin Locus Are Independent of the Locus Control Region Molecular and Cellular Biology ·Daniel Cimbora, Dirk Schübeler, Andreas Reik, Joan Hamilton, Claire Francastel, Elliot Epner, Mark Groudine	2000	97
7	B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets Therapeutic Advances in Neurological Disorders ·Thomas G. Forsthuber, Daniel Cimbora, John N. Ratchford, Eliezer Katz, Olaf Stüve	2018	90
8	Marine Natural Product Libraries for High-Throughput Screening and Rapid Drug Discovery Journal of Natural Products ·Tim S. Bugni, Burt T. Richards, Leen Bhoite, Daniel Cimbora, Mary Kay Harper, Chris M. Ireland	2008	90
9	Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study Arthritis Research & Therapy ·Elena Schiopu, Soumya Chatterjee, Vivien Hsu, Armando Flor, Daniel Cimbora, Kaushik Patra, Wenliang Yao, Jing Li, Katie Streicher, Kathleen McKeever, Barbara White, Eliezer Katz, Jörn Drappa, Sarah Sweeny, Ronald Herbst	2016	60
10	Replication Initiation Patterns in the β-Globin Loci of Totipotent and Differentiated Murine Cells: Evidence for Multiple Initiation Regions Molecular and Cellular Biology ·Mirit I. Aladjem, Luo Wei Rodewald, Chii Mai Lin, Sarah Bowman, Daniel Cimbora, Linnea L. Brody, Elliot Epner, Mark Groudine, Geoffrey M. Wahl	2002	50
11	2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97) Bioorganic & Medicinal Chemistry Letters ·Matthew G. Bursavich, Daniel P. Parker, J. Adam Willardsen, Zhong‐Hua Gao, Thaylon Davis, Kirill Ostanin, Rosann Robinson, Ashley Peterson, Daniel Cimbora, Ju-Fen Zhu, Burt T. Richards	2010	49
12	Drosophila Midgut Morphogenesis Requires the Function of the Segmentation Gene odd-paired Developmental Biology ·Daniel Cimbora, Shigeru Sakonju	1995	48
13	Long-term efficacy and safety of inebilizumab in neuromyelitis optica spectrum disorder: Analysis of aquaporin-4–immunoglobulin G–seropositive participants taking inebilizumab for ⩾4 years in the N-MOmentum trial Multiple Sclerosis Journal ·Mary Rensel, Aram Zabeti, Maureen A. Mealy, Daniel Cimbora, Dewei She, Jörn Drappa, Eliezer Katz	2021	41
14	The Control of Mammalian DNA Replication Cell ·Daniel Cimbora, Mark Groudine	2001	37
15	Discovery of (2S)-1-[4-(2-{6-Amino-8-[(6-bromo-1,3-benzodioxol-5-yl)sulfanyl]-9H-purin-9-yl}ethyl)piperidin-1-yl]-2-hydroxypropan-1-one (MPC-3100), a Purine-Based Hsp90 Inhibitor Journal of Medicinal Chemistry ·Seho Kim, Ashok C. Bajji, Rajendra Tangallapally, Benjamin Markovitz, Richard Trovato, Mark D. Shenderovich, Vijay Baichwal, Paul L. Bartel, Daniel Cimbora, Rena McKinnon, Rosann Robinson, Damon I. Papac, Dániel Wettstein, Robert Carlson, Kraig M. Yager	2012	36
16	Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors Bioorganic & Medicinal Chemistry Letters ·Dhiraj Kumar, Christophe Hoarau, Matthew G. Bursavich, Paul Slattum, David Gerrish, Kraig M. Yager, Michael Saunders, Mark D. Shenderovich, Bruce L. Roth, Rena McKinnon, Ashley Chan, Daniel Cimbora, Chad Bradford, Leslie Reeves, Scott Patton, Damon I. Papac, Brandi L. Williams, Robert Carlson	2012	26
17	Inebilizumab for treatment of neuromyelitis optica spectrum disorder in patients with prior rituximab use from the N-MOmentum Study Multiple Sclerosis and Related Disorders ·Eoin P. Flanagan, Michael Levy, Eliezer Katz, Daniel Cimbora, Jörn Drappa, Maureen A. Mealy, Dewei She, Bruce Cree	2021	26
18	AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder Multiple Sclerosis and Related Disorders ·Romain Marignier, Sean J Pittock, Friedemann Paul, Ho Jin Kim, Jeffrey L. Bennett, Brian G. Weinshenker, Dean M. Wingerchuk, Ari Green, Kazuo Fujihara, Gary Cutter, Orhan Aktaş, Hans‐Peter Hartung, Jörn Drappa, John N. Ratchford, Dewei She, Michael Smith, William A. Rees, Daniel Cimbora, Eliezer Katz, Bruce Cree	2021	24
19	Oxindole derivatives as inhibitors of TAK1 kinase Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Lockman, Matthew D. Reeder, Rosann Robinson, Patricia A. Ormonde, Daniel Cimbora, Brandi L. Williams, J. Adam Willardsen	2011	24
20	Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial The Lancet Neurology ·Bruce Cree, Ho Jin Kim, Brian G. Weinshenker, Sean J. Pittock, Dean M. Wingerchuk, Kazuo Fujihara, Friedemann Paul, Gary Cutter, Romain Marignier, Ari Green, Orhan Aktaş, Hans‐Peter Hartung, Dewei She, William A. Rees, Michael Smith, Daniel Cimbora, Eliezer Katz, Jeffrey L. Bennett	2024	20

About Daniel Cimbora

Daniel Cimbora is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Immunology, Neurology and Cell Biology, having authored 36 papers that have together received 2.2k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (11 papers), Peripheral Neuropathies and Disorders (7 papers), Genomics and Chromatin Dynamics (6 papers), DNA and Nucleic Acid Chemistry (5 papers), Epigenetics and DNA Methylation (4 papers), Microtubule and mitosis dynamics (3 papers), Immunotherapy and Immune Responses (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Virology (276 citations), Cell Biology (421 citations), Molecular Biology (1.4k citations), Immunology (307 citations) and Pathology and Forensic Medicine (236 citations). Daniel Cimbora has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Mark Groudine, Andreas Reik, Dirk Schübeler, David I. K. Martin, Claire Francastel, Elliot Epner, Agnes Telling, Thaylon Davis, Jerry Kaplan and Scott G. Morham. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecular and Cellular Biology, Multiple Sclerosis Journal, Cancer Research and Multiple Sclerosis and Related Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact